Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on visible light photocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114874139A details a green visible-light method for synthesizing dihydroisoquinoline intermediates, offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Patent CN108299296A details a visible-light induced synthesis of phenanthridine derivatives using organic photocatalysts, offering cost-effective and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN111072605B details a visible-light catalyzed method for fluoroalkyl-substituted benzofurans. Offers mild conditions and high yields for pharma intermediates.
Patent CN110540516B details a mild visible-light protocol for dihydronaphthalenes, offering cost-effective routes for pharmaceutical intermediates.
Patent CN110540516B reveals visible-light mediated synthesis of dihydronaphthalenes. High yield, mild conditions, reliable pharmaceutical intermediate supplier.
Patent CN111892545A reveals a green photocatalytic route for quinoxalinones. Achieve high yields without transition metals, ensuring cost reduction in API manufacturing and reliable supply.
Patent CN112898202B discloses a mild photocatalytic route to heterocyclic cyclopropanes. This technology offers cost reduction in pharmaceutical intermediate manufacturing through scalable, visible-light catalysis.
Patent CN117088826B enables visible light synthesis of oxazoles. Offers green chemistry solutions for reliable pharmaceutical intermediates supplier partners seeking cost reduction.
Novel visible light photocatalysis method for C2-difluoroalkylbenzimidazole derivatives offers mild conditions and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN105669522B reveals metal-free visible light synthesis for high-purity indolinones offering substantial cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Novel visible-light catalyzed method for 3-alkyl quinoxalin-2(1H)-ones. High yield, mild conditions, scalable process for pharmaceutical intermediates.
Novel visible-light driven Ru-catalyst enables room-temp alkyne-aldehyde addition. Reduces energy costs and simplifies supply chain for API synthesis.
Patent CN117304094A reveals visible-light method for high-purity 3-trifluoromethylpyridine. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel patent CN114573512B enables mild visible light synthesis. Reduces toxicity and cost for pharmaceutical intermediates manufacturing supply chain.
Patent CN114874139A details a green visible-light method for 1-benzyl-3,4-dihydroisoquinoline. Offers cost-effective, scalable pharma intermediate production.
Patent CN110540516B reveals a mild visible-light mediated synthesis for dihydronaphthalene derivatives, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN110305054B details a green FeBr3-catalyzed route for N-(1-phenyl-2-(phenylseleno)ethyl)aniline derivatives, offering cost reduction and scalable manufacturing.
Patent CN114560832A reveals a green two-step route to dibenzofurans using visible light and palladium catalysis, offering cost-effective manufacturing solutions.
Patent CN112047839B reveals a visible-light driven method for high-purity 1-iodo-3-perfluoroalkyl alkenes. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN112028841A reveals a catalyst-free visible light method for high-yield quinoxalinone synthesis, offering significant cost reduction in pharmaceutical intermediate manufacturing.